Investor Alert

Apellis Pharmaceuticals Inc.



After Hours

 --Quotes are delayed by 20 min

Jun 27, 2022, 4:47 p.m.





0.00 0.00%


Volume 74,943

Quotes are delayed by 20 min


Previous close

$ 46.26

$ 46.39


+0.13 +0.28%

Day low

Day high




52 week low

52 week high




Annual Financials for Apellis Pharmaceuticals Inc.


Fiscal year is January-December. All values USD millions. 20172018201920202021 5-year trend
Cash & Short Term Investments 175.64M176.27M351.99M878.91M702.11M
Cash Only 175.64M176.27M351.99M567.05M641.76M
Short-Term Investments ---311.87M60.36M
Total Accounts Receivable ----10.1M
Accounts Receivables, Net ----10.1M
Accounts Receivables, Gross ----10.1M
Bad Debt/Doubtful Accounts -----
Other Receivables -----
Inventories ----16.29M
Finished Goods ----10.6M
Work in Progress -----
Raw Materials ----5.7M
Progress Payments & Other -----
Other Current Assets 6.37M26.17M21.11M38.28M95.55M
Miscellaneous Current Assets 1.31M1.84M1.31M26.88M70.68M
Total Current Assets 182.02M202.44M373.09M917.19M824.05M
20172018201920202021 5-year trend
Net Property, Plant & Equipment --15.77M24.52M26.08M
Property, Plant & Equipment - Gross -----
Buildings -----
Land & Improvements -----
Computer Software and Equipment -----
Other Property, Plant & Equipment -----
Accumulated Depreciation -----
Total Investments and Advances -----
Other Long-Term Investments -----
Long-Term Note Receivable -----
Intangible Assets -----
Net Goodwill -----
Net Other Intangibles -----
Other Assets 116,1501.09M385,09018.86M31.64M
Tangible Other Assets 116,1501.09M385,08818.86M31.64M
Total Assets 182.13M203.53M389.24M960.57M881.77M

Liabilities & Shareholders' Equity

20172018201920202021 5-year trend
ST Debt & Current Portion LT Debt -1.67M2.61M3.69M4.12M
Short Term Debt --2.61M3.69M-
Current Portion of Long Term Debt -1.67M---
Accounts Payable --8.36M8.48M16.91M
Income Tax Payable -----
Other Current Liabilities 6.55M15.36M54.78M116.17M110.82M
Dividends Payable -----
Accrued Payroll 251,491269,04611.44M22.9M25.21M
Miscellaneous Current Liabilities 6.3M15.09M43.34M93.27M85.61M
Total Current Liabilities 6.55M17.02M65.75M128.33M131.85M
Long-Term Debt 26.39M25.38M154.42M374.05M206.11M
Long-Term Debt excl. Capitalized Leases 26.39M25.38M142.57M358.83M189.02M
Non-Convertible Debt 26.39M25.38M142.57M358.83M189.02M
Convertible Debt -----
Capitalized Lease Obligations -----
Provision for Risks & Charges -----
Deferred Taxes -----
Deferred Taxes - Credit -----
Deferred Taxes - Debit -----
Other Liabilities 244,290158,780134.84M253.64M345.15M
Other Liabilities (excl. Deferred Income) 244,292158,783134.84M253.64M345.15M
Deferred Income -----
Total Liabilities 33.19M42.56M355.02M756.01M683.1M
Non-Equity Reserves -----
Preferred Stock (Carrying Value) -----
Redeemable Preferred Stock -----
Non-Redeemable Preferred Stock -----
Common Equity (Total) 148.94M160.97M34.23M204.56M198.66M
Common Stock Par/Carry Value 5,0335,6286,3938,00010,000
Retained Earnings (149.26M)(276.77M)(581.47M)(926.35M)(1.66B)
ESOP Debt Guarantee -----
Cumulative Translation Adjustment/Unrealized For. Exch. Gain -(122,807)(153,775)(109,000)(2.09M)
Unrealized Gain/Loss Marketable Securities ---(8,000)1,000
Revaluation Reserves -----
Treasury Stock -----
Total Shareholders' Equity 148.94M160.97M34.23M204.56M198.66M
Accumulated Minority Interest -----
Total Equity 148.94M160.97M34.23M204.56M198.66M
Liabilities & Shareholders' Equity 182.13M203.53M389.24M960.57M881.77M
Link to MarketWatch's Slice.